AnGes: AnGes : Submits Application for Marketing Approval to PMDA for HGF gene therapy for Critical Limb Ischemia

(4-traders.com) January 22, 2018 AnGes, Inc. AnGes Submits Application for Marketing Approval to PMDA for HGF gene therapy for Critical Limb Ischemia AnGes, Inc., a biopharmaceutical company focused on developing innovative gene-based medicines for serious...http://www.4-traders.com/ANGES-INC-6814797/news/AnGes-Submits-Application-for-Marketing-Approval-to-PMDA-for-HGF-gene-therapy-for-Critical-Limb-Is-25847955/?utm_medium=RSS&utm_content=20180122